Immunotherapy

See highlights stemming from paper published in the journal Nature on Oct. 22.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.

Under new $2.6 million NIH grant MBI researchers will investigate why some patients respond to dendritic cell therapy and some do not.

Drs. Jianping Huang and John Ligon have launched a human clinical trial to test an immunotherapy treatment for children with high-grade gliomas.

Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.

Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.

Dr. Jianping Huang and colleagues publish paper in the journal Acta Biomaterialia.

Videos aired during The V Foundation's "V Week" highlight UF Health’s efforts to fight brain cancer.

Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.

Dr. Carlos Rinaldi-Ramos will lead projects involving Drs. Lan Hoang-Minh and Duane Mitchell, and Drs. Marcelo Febo and Lakeisha Williams.